Adcirca is authorised to treat a form of superior blood pressure with your lungs identified as pulmonary arterial hypertension (PAH). The drug is approved for use in males and women. PAH is a selected kind of pulmonary hypertension that occurs while in the arteries within your lungs.In some instances, the model-identify drug and the generic version